IGF2 and adrenal cortex carcinoma: Two major studies of the molecular basis of ACC—Assie et al. [12] and Zheng et al. [13]—demonstrated that loss of heterozygosity of the IGF2 locus is a common event in ACC leading to upregulation of IGF2/IGF1R signaling.